CICOIRA, Mariantonietta
 Distribuzione geografica
Continente #
EU - Europa 4.972
NA - Nord America 4.794
AS - Asia 2.971
SA - Sud America 572
AF - Africa 57
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 13.378
Nazione #
US - Stati Uniti d'America 4.717
RU - Federazione Russa 1.654
GB - Regno Unito 1.649
SG - Singapore 1.365
CN - Cina 868
BR - Brasile 480
FR - Francia 324
HK - Hong Kong 290
DE - Germania 272
FI - Finlandia 239
IE - Irlanda 234
SE - Svezia 209
IT - Italia 193
VN - Vietnam 171
UA - Ucraina 99
KR - Corea 90
CA - Canada 33
AR - Argentina 29
TR - Turchia 27
IN - India 23
BD - Bangladesh 22
MX - Messico 22
EC - Ecuador 20
ID - Indonesia 18
ZA - Sudafrica 18
BE - Belgio 16
IQ - Iraq 14
AT - Austria 12
CL - Cile 11
NL - Olanda 11
PL - Polonia 11
IL - Israele 10
JP - Giappone 10
MA - Marocco 9
LT - Lituania 8
PE - Perù 8
PH - Filippine 8
CO - Colombia 7
EG - Egitto 7
KE - Kenya 7
UZ - Uzbekistan 7
VE - Venezuela 7
AU - Australia 6
ES - Italia 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
JO - Giordania 5
PK - Pakistan 5
DO - Repubblica Dominicana 4
IR - Iran 4
OM - Oman 4
RO - Romania 4
SA - Arabia Saudita 4
UY - Uruguay 4
BG - Bulgaria 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
DK - Danimarca 3
DZ - Algeria 3
ET - Etiopia 3
PA - Panama 3
PS - Palestinian Territory 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
BY - Bielorussia 2
CH - Svizzera 2
DM - Dominica 2
EU - Europa 2
GA - Gabon 2
GR - Grecia 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MD - Moldavia 2
MY - Malesia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
BZ - Belize 1
CG - Congo 1
CU - Cuba 1
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
Totale 13.370
Città #
Southend 1.516
Jacksonville 810
Singapore 653
Woodbridge 581
Chandler 509
Moscow 444
Dallas 409
Ann Arbor 333
Hong Kong 290
Ashburn 281
Houston 255
Dublin 233
Beijing 157
Lawrence 121
Princeton 121
The Dalles 100
Wilmington 98
Nanjing 89
Verona 70
Los Angeles 69
Sindelfingen 66
Jinan 62
Buffalo 59
Ho Chi Minh City 47
São Paulo 47
New York 37
Boardman 36
Shenyang 35
Munich 33
Redondo Beach 33
Hebei 32
Tianjin 32
Columbus 31
Changsha 27
Milan 26
Hanoi 25
Hangzhou 24
Helsinki 22
Zhengzhou 21
Dong Ket 20
Norwalk 20
Santa Clara 20
Nanchang 19
Taiyuan 18
Guangzhou 17
Brussels 16
Ningbo 16
Fairfield 14
Rio de Janeiro 14
Taizhou 14
Brasília 13
Haikou 13
Jiaxing 13
Turku 13
Jakarta 12
Montreal 11
Chicago 10
Düsseldorf 10
Falkenstein 10
Fuzhou 10
Belo Horizonte 9
Frankfurt am Main 9
London 9
San Francisco 9
San Jose 9
Stockholm 9
Toronto 9
Washington 9
Boston 8
Council Bluffs 8
Guayaquil 8
Haiphong 8
Lancaster 8
Lanzhou 8
Nuremberg 8
Seattle 8
Warsaw 8
Biên Hòa 7
Dhaka 7
Johannesburg 7
Mexico City 7
Tashkent 7
Tokyo 7
Auburn Hills 6
Bologna 6
Brooklyn 6
Buenos Aires 6
Campinas 6
Denver 6
Falls Church 6
Kent 6
Nairobi 6
Amman 5
Baguio City 5
Curitiba 5
Da Nang 5
Duque de Caxias 5
Fortaleza 5
Hải Dương 5
Manchester 5
Totale 8.417
Nome #
Exercise tolerance can explain the obesity paradox in patients with systolic heart failure: data from the MECKI Score Research Group 708
Aortic and mitral annular calcification are predictive of all-cause and cardiovascular mortality in patients with type 2 diabetes. 211
Cardiorenal Syndrome Type 1: Pathophysiological Crosstalk Leading to Combined Heart and Kidney Dysfunction in the Setting of Acutely Decompensated Heart Failure. 209
Aortic stiffness correlates with an increased extracellular matrix turnover in patients with dilated cardiomyopathy. 185
Aortic distensibility independently affects exercise tolerance in patients with dilated cardiomyopathy. 175
Additional value of pulmonary vein parameters in defining pseudonormalization of mitral inflow pattern. 160
Alterazioni muscolari e intolleranza allo sforzo nello scompenso cardiaco congestizio: ruolo centrale della periferia 157
Increased aortic pulse wave velocity as measured by echocardiography is strongly associated with poor prognosis in patients with heart failure. 156
Cardio-renal cachexia syndromes (CRCS): pathophysiological foundations of a vicious pathological circle. 155
Beta-blockers can improve survival in medically-treated patients with severe symptomatic aortic stenosis 153
Relationship between mitral regurgitation and myocardial viability after acute myocardial infarction: their impact on prognosis 152
A higher body mass index is associated with reduced prevalence of unstable atherosclerotic plaque: A possible explanation of the obesity paradox. 150
Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. 149
Echocardiographically Derived Pulse Wave Velocity and Diastolic Dysfunction Are Associated with an Increased Incidence of Atrial Fibrillation in Patients with Systolic Heart Failure 148
The role of angiotensin-converting enzyme polymorphism in congestive heart failure. 145
Association of deranged adrenal steroid metabolism with anemia in chronic heart failure. 145
Biventricular pacing. 145
Amino-terminal propeptide of type III procollagen is associated with restrictive mitral filling pattern in patients with dilated cardiomyopathy: a possible link between diastolic dysfunction and prognosis. 145
Aortic valve sclerosis: a marker of significant obstructive coronary artery disease in patients with chest pain? 140
Body mass index, prognosis and mode of death in chronic heart failure: Results from the Valsartan Heart Failure Trial. 138
Aortic distensibility independently affects exercise tolerance in patients with dilated cardiomyopathy 137
Skeletal muscle mass independently predicts peak oxygen consumption and ventilatory response during exercise in noncachectic patients with chronic heart failure. 136
Aortic valve sclerosis is a marker of atherosclerosis independently of traditional clinical risk factors. Analysis in 712 patients without ischemic heart disease. 135
Left Atrial Volume Provides Independent and Incremental Information Compared With Exercise Tolerance Parameters in Patients With Heart Failure and Left Ventricular Systolic Dysfunction. 130
Association of aortic valve sclerosis and coronary artery disease in patients with severe nonischemic mitral regurgitation. 130
Predicting heart failure outcome from cardiac and comorbid conditions: The 3C-HF score. 129
Chronic heart failure and cardiac cachexia and links between the endocrine and immune system 127
Determinants of exercise intolerance symptoms considered non-specific for heart failure in patients with stage A and B: role of the left atrium in the transition phase to overt heart failure 127
Left atrial overload can be used to estimate mitral regurgitant volume. 125
Aortic stiffness: an old concept for new insights into the pathophysiology of functional mitral regurgitation. 125
Echocardiographic advances in hypertrophic cardiomyopathy: Three-dimensional and strain imaging echocardiography 123
ESPEN Guidelines on Enteral Nutrition: Cardiology and pulmonology. 121
Mitral regurgitation and dyspnoea: The expanding role of mitral effective regurgitant orifice among un-selected patients 121
Growth hormone resistance in chronic heart failure and its therapeutic implications. 119
High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients. 119
Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. 119
Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients 118
Prognostic implications of evaluation of contractile reserve in akinetic and hypokinetic segments during low dose dobutamine echocardiography in patients with acute myocardial infarction. 118
Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure. 117
Fill in the Gaps of Secondary Mitral Regurgitation: a Continuum Challenge From Pathophysiology to Prognosis 117
Ambient air pollution as a new risk factor for cardiovascular diseases: Time to take action 116
Role of growth hormone in chronic heart failure: therapeutic implications 114
Functional mitral regurgitation in patients with aortic stenosis: prevalence, clinical correlates and pathophysiological determinants: a quantitative prospective study. 114
Carotid atherosclerotic plaque instability in patients with acute myocardial infarction. 112
Impact of body mass index on short-term outcome after acute myocardial infarction: does excess body weight have a paradoxical protective role? 112
Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation. 111
Elevated serum uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathy. 110
Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia 110
Echocardiographic determinants of mortality in patients 67 years of age with chronic heart failure 110
Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype 110
Myocardial viability independently influences left ventricular diastolic function in the early phase after acute myocardial infarction. 110
Role of growth hormone in chronic heart failure 109
Growth hormone treatment in chronic heart failure: lessons from the first 99 patients 109
Mitral regurgitation, left atrial structural and functional remodelling and the effect on pulmonary haemodynamics 108
Inhibitors of angiotensin-converting enzyme and physical function in older women. 107
Identification of High-Risk Chronic Heart Failure Patients in Clinical Practice: Role of Changes in Left Ventricular Function. 106
Relevance of Functional Mitral Regurgitation in Aortic Valve Stenosis 106
Chronic heart failure with preserved left ventricular ejection fraction: Diagnostic and prognostic value of left atrial size. 105
Mitral regurgitation and left ventricular diastolic dysfunction similarly affect mitral and pulmonary vein flow Doppler parameters: the advantage of end-diastolic markers. 105
Uric acid and survival in chronic heart failure: validation and application in metabolic, functional and hemodynamic staging. 103
Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients. 103
Prognostic value of detection of myocardial viability using low-dose dobutamine echocardiography in infarcted patients 103
Relation of aldosterone "escape" despite angiotensin-converting enzyme inhibitor administration to impaired exercise capacity in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. 102
Independent and additional prognostic value of aminoterminal propeptide of type III procollagen circulating levels in patients with chronic heart failure. 100
Chronic heart failure in the very elderly: clinical status, survival and prognostic factors in 188 patients more than 70 years old 99
Mineralocorticoid receptor antagonists for heart failure: a real-life observational study 99
Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure. 97
Outpatients electrical cardioversion of atrial fibrillation: 8 years' experience. Analysis of shock-related arrhythmias. 97
Enhanced prognostic value from cardiopulmonary exercise testing in chronic heart failure by non-linear analysis: oxygen uptake efficiency slope. 96
Long-term prognostic value of the stenosis of the infarct-related artery and the presence of viable myocardium in akinetic ventricular regions in infarcted patients 96
Renal arterial pulsatility predicts progression of chronic kidney disease in chronic heart failure patients. 96
Emerging strategies for chronic heart failure: the role of gene therapy 95
Determinants and prognostic value of left atrial volume in patients with dilated cardiomyopathy. 94
Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not norepinephrine or TNF-alpha 93
Prediction of mortality in chronic heart failure from peak oxygen consumption adjusted for either body weight or lean tissue. 92
Prognostic relevance of pulmonary arterial compliance in patients with chronic heart failure. 92
Clinical characteristics and survival of patients with chronic heart failure and prolonged QRS duration 91
Exercise Performance Is a Prognostic Indicator in Elderly Patients With Chronic Heart Failure--Application of Metabolic Exercise Cardiac Kidney Indexes Score 91
Mitral and aortic valve sclerosis/calcification and carotid atherosclerosis: results from 1065 patients. 88
Heart failure and anemia: Effects on prognostic variables 88
The influence of confounders in the analysis of mid-regional pro-atrial natriuretic peptide in patients with chronic heart failure 88
Effects of ace gene insertion/deletion polymorphism on response to spironolactone in patients with chronic hearth failure. 87
Ischemic etiology of heart failure identifies patients with more severely impaired exercise capacity. 87
Effects on survival of loop diuretic dosing in ambulatory patients with chronic heart failure using a propensity score analysis 87
Elevated serum uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathy. 86
Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure. 86
Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias 86
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 86
Heart failure in women treated with adjuvant trastuzumab fro breast cancer. 85
Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition. 84
Role of clinical evaluation and functional testing in the tailored follow-up of chronic heart failure patients 84
Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure 84
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction 84
Identification of chronic heart failure patients with a high 12-month mortality risk using biomarkers including plasma C-terminal pro-endothelin-1. 83
Prognostic utlity of growth differentiation factor-15 in patients with chronic heart failure 82
Severe acute left ventricular dysfunction in multiple sclerosis: a case report and review of the literature. 81
Prognostic relevance of a non-invasive evaluation of right ventricular function and pulmonary artery pressure in patients with chronic heart failure. 80
Myocardial infarction in a young patient with a previous history of repeated thrombophlebitis: combination of factor V Leiden and prothrombin G20210A gene polymorphisms with coronary artery disease. 79
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison. 79
Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow. 78
Totale 11.994
Categoria #
all - tutte 46.619
article - articoli 46.619
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.238


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021534 0 0 0 0 0 121 19 95 89 25 130 55
2021/2022723 78 191 18 29 17 28 10 46 23 30 66 187
2022/20231.590 143 119 192 254 156 359 13 119 157 10 46 22
2023/2024659 23 82 58 108 87 71 17 44 3 18 108 40
2024/20252.196 150 162 46 358 75 77 133 114 303 164 146 468
2025/20263.592 448 307 446 837 1.239 315 0 0 0 0 0 0
Totale 13.497